TScan TherapeuticsTCRX
那斯達克 · USD
1.62
-0.12
(-6.90%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
TScan TherapeuticsTCRX
1.62
-0.12
(-6.90%)
財務數據
損益表
- 0.03
- 0.07
- 0.03
- 0.04
- 0.07
- 0.01
- 0.01
- 0.01
- 0.01
- 0.02
- -7.97
- 119.81
- 0.00
- 23.48
- 85.52
- -92.15
- -5.30
- 95.71
- -36.61
- 226.47
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 2,171 | 665 | 1,049 | 536 | 566 | 7,211 | 3,887 | 3,148 | 6,803 | 3,095 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 2,171 | 665 | 1,049 | 536 | - | 7,211 | 3,887 | 3,148 | 6,803 | 3,095 |
營業費用 | 38,421 | 37,377 | 33,671 | 34,650 | - | 28,568 | 28,635 | 27,758 | 29,546 | 21,744 |
研發費用 | 29,788 | 29,354 | 26,262 | 26,877 | 24,857 | 22,406 | 22,741 | 21,227 | 21,779 | 15,604 |
推銷及管理費用 | 8,633 | 8,023 | 7,409 | 7,773 | 7,082 | 6,162 | 5,894 | 6,531 | 7,767 | 6,140 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -36,250 | -36,712 | -32,622 | -34,114 | -31,373 | -21,357 | -24,748 | -24,610 | -22,743 | -18,649 |
其他收入及費用 | 2,802 | 1,687 | 3,693 | 3,405 | 2,190 | 2,596 | 2,733 | 1,534 | 1,136 | 901 |
利息費用 | 679 | 784 | 958 | 952 | 959 | 852 | 982 | 969 | 956 | 975 |
稅前純益 | -34,127 | -35,809 | -29,887 | -31,661 | -30,142 | -19,613 | -22,997 | -24,045 | -22,563 | -18,723 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -34,127 | -35,809 | -29,887 | -31,661 | -30,142 | -19,613 | -22,997 | -24,045 | -22,563 | -18,723 |
基本每股稅後盈餘(元) | -0.26 | -0.30 | -0.25 | -0.28 | -0.32 | - | -0.24 | -0.51 | -0.51 | -0.78 |
稀釋每股稅後盈餘(元) | -0.26 | -0.30 | -0.25 | -0.27 | -0.32 | -0.11 | 0.05 | -0.37 | -0.93 | -0.77 |
基本平均股數(千股) | 129678.00 | 120789.00 | 118700.00 | 113425.00 | 94875.00 | - | 94829.00 | 47208.00 | 47208.00 | 24077.00 |
稀釋平均股數(千股) | 129678.00 | 120789.00 | 118700.00 | 113425.00 | 94875.00 | - | 94829.00 | 47208.00 | 47208.00 | 24077.00 |
還原基本每股稅後盈餘(元) | -0.26 | -0.30 | -0.25 | -0.28 | -0.32 | - | -0.24 | -0.51 | -0.51 | -0.78 |
還原稀釋每股稅後盈餘(元) | -0.26 | -0.30 | -0.25 | -0.27 | -0.32 | -0.11 | 0.05 | -0.37 | -0.93 | -0.77 |
還原基本平均股數(千股) | 129,678 | 120,789 | 118,700 | 113,425 | 94,875 | - | 94,829 | 47,208 | 47,208 | 24,077 |
還原稀釋平均股數(千股) | 129,678 | 120,789 | 118,700 | 113,425 | 94,875 | - | 94,829 | 47,208 | 47,208 | 24,077 |
EBITDA(千元) | -34,047 | -35,864 | -29,403 | -29,986 | -28,382 | -18,318 | -20,964 | -21,780 | -20,108 | -16,264 |